Laboratorios Farmaceuticos ROVI (ROVI) — Financial Flexibility Index
Laboratorios Farmaceuticos ROVI (ROVI) has a Financial Flexibility Index of 0.31x as of September 2025. Free cash flow of €91.00 Million (operating CF €73.37 Million minus capex €17.62 Million) represents 0% of total liabilities (€289.27 Million). Check Laboratorios Farmaceuticos ROVI (ROVI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Laboratorios Farmaceuticos ROVI Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Laboratorios Farmaceuticos ROVI across 19 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Laboratorios Farmaceuticos ROVI.
Annual Financial Flexibility Index for Laboratorios Farmaceuticos ROVI (2006–2024)
Year-by-year free cash flow to debt coverage for Laboratorios Farmaceuticos ROVI. Explore how well can Laboratorios Farmaceuticos ROVI service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €200.50 Million | €138.28 Million | €250.48 Million | ▲ +21.8% |
| 2023 | 0.66x | €168.43 Million | €113.25 Million | €256.39 Million | ▼ -18.8% |
| 2022 | 0.81x | €288.99 Million | €237.60 Million | €357.32 Million | ▲ +11.2% |
| 2021 | 0.73x | €190.38 Million | €149.44 Million | €261.70 Million | ▲ +68.7% |
| 2020 | 0.43x | €86.57 Million | €46.88 Million | €200.74 Million | ▲ +158.7% |
| 2019 | 0.17x | €31.48 Million | €-9.04 Million | €188.82 Million | ▼ -45.1% |
| 2018 | 0.30x | €34.99 Million | €8.53 Million | €115.23 Million | ▼ -14.7% |
| 2017 | 0.36x | €37.98 Million | €18.04 Million | €106.69 Million | ▼ -41.5% |
| 2016 | 0.61x | €63.60 Million | €45.53 Million | €104.44 Million | ▲ +22.4% |
| 2015 | 0.50x | €49.29 Million | €29.39 Million | €99.06 Million | ▲ +6.5% |
| 2014 | 0.47x | €48.06 Million | €23.00 Million | €102.85 Million | ▼ -21.6% |
| 2013 | 0.60x | €54.50 Million | €29.82 Million | €91.46 Million | ▲ +71.5% |
| 2012 | 0.35x | €33.33 Million | €19.61 Million | €95.92 Million | ▲ +88.5% |
| 2011 | 0.18x | €21.04 Million | €12.68 Million | €114.09 Million | ▼ -25.1% |
| 2010 | 0.25x | €26.77 Million | €21.19 Million | €108.75 Million | ▲ +84.3% |
| 2009 | 0.13x | €12.61 Million | €9.62 Million | €94.42 Million | ▼ -57.0% |
| 2008 | 0.31x | €22.40 Million | €12.66 Million | €72.11 Million | ▲ +45.2% |
| 2007 | 0.21x | €12.88 Million | €1.15 Million | €60.23 Million | ▼ -8.7% |
| 2006 | 0.23x | €11.76 Million | €7.72 Million | €50.23 Million | — |